Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Contemporary costs of HIV healthcare in the HAART era.

Gebo KA, Fleishman JA, Conviser R, Hellinger J, Hellinger FJ, Josephs JS, Keiser P, Gaist P, Moore RD; HIV Research Network.

AIDS. 2010 Nov 13;24(17):2705-15. doi: 10.1097/QAD.0b013e32833f3c14.

2.

HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.

Chander G, Himelhoch S, Fleishman JA, Hellinger J, Gaist P, Moore RD, Gebo KA.

AIDS Care. 2009 May;21(5):655-63. doi: 10.1080/09540120802459762.

3.

Alternatives to the randomized controlled trial.

West SG, Duan N, Pequegnat W, Gaist P, Des Jarlais DC, Holtgrave D, Szapocznik J, Fishbein M, Rapkin B, Clatts M, Mullen PD.

Am J Public Health. 2008 Aug;98(8):1359-66. doi: 10.2105/AJPH.2007.124446. Epub 2008 Jun 12.

4.

Alcohol use among HIV-infected persons in care: results of a multi-site survey.

Chander G, Josephs J, Fleishman JA, Korthuis PT, Gaist P, Hellinger J, Gebo K; HIV Research Network.

HIV Med. 2008 Apr;9(4):196-202. doi: 10.1111/j.1468-1293.2008.00545.x.

5.

The impact of illicit drug use and substance abuse treatment on adherence to HAART.

Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, Hellinger J, Gaist P, Gebo KA; HIV Research Network.

AIDS Care. 2007 Oct;19(9):1134-40.

6.

Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.

Himelhoch S, Chander G, Fleishman JA, Hellinger J, Gaist P, Gebo KA.

Gen Hosp Psychiatry. 2007 Nov-Dec;29(6):518-25.

7.

HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.

Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG.

BMC Health Serv Res. 2007 Jul 12;7:108.

8.

Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS.

Josephs JS, Fleishman JA, Gaist P, Gebo KA; HIV Research Network.

HIV Med. 2007 Jul;8(5):300-5.

PMID:
17561876
9.

Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project.

Marseille E, Dandona L, Saba J, McConnel C, Rollins B, Gaist P, Lundberg M, Over M, Bertozzi S, Kahn JG.

Health Serv Res. 2004 Dec;39(6 Pt 2):1993-2012. Review. Erratum in: Health Serv Res. 2005 Feb;40(1):309.

10.

Ethical issues in research on preventing HIV infection among injecting drug users.

Des Jarlais DC, Gaist PA, Friedman SR.

Sci Eng Ethics. 1995 Apr;1(2):133-44. No abstract available.

PMID:
11660709
11.

Effects of bright light on resting metabolic rate in patients with seasonal affective disorder and control subjects.

Gaist PA, Obarzanek E, Skwerer RG, Duncan CC, Shultz PM, Rosenthal NE.

Biol Psychiatry. 1990 Dec 1;28(11):989-96.

PMID:
2275956
12.

Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.

Kasper S, Wehr TA, Bartko JJ, Gaist PA, Rosenthal NE.

Arch Gen Psychiatry. 1989 Sep;46(9):823-33.

PMID:
2789026
13.

Neurobiology of seasonal affective disorder and phototherapy.

Skwerer RG, Jacobsen FM, Duncan CC, Kelly KA, Sack DA, Tamarkin L, Gaist PA, Kasper S, Rosenthal NE.

J Biol Rhythms. 1988 Summer;3(2):135-54. Review. No abstract available.

PMID:
2979636
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk